Heterologous Biosynthesis, Modifications and Structural Characterization of Ruminococcin-A, a Lanthipeptide From the Gut Bacterium Ruminococcus gnavus E1, in Escherichia coli-Reference-Cited by-同舟云学术

Heterologous Biosynthesis, Modifications and Structural Characterization of Ruminococcin-A, a Lanthipeptide From the Gut Bacterium Ruminococcus gnavus E1, in Escherichia coli

Published:2018-07-26 Issue: Volume:9 Page:
ISSN:1664-302X
Container-title:Frontiers in Microbiology
language:
Short-container-title:Front. Microbiol.

Author:

Ongey Elvis L.,Giessmann Robert T.,Fons Michel,Rappsilber Juri,Adrian Lorenz,Neubauer Peter

Funder

Deutsche Forschungsgemeinschaft

Deutscher Akademischer Austauschdienst

Publisher

Frontiers Media SA

Subject

Microbiology (medical),Microbiology

Reference53 articles.

1. Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis.;Agustin;Eur. J. Biochem.,1992

2. Pseudomycoicidin, a class II lantibiotic from Bacillus pseudomycoides.;Basi-Chipalu;Appl. Environ. Microbiol.,2015

3. Organization of the biosynthetic genes encoding deoxyactagardine B (DAB), a new lantibiotic produced by Actinoplanes liguriae NCIMB41362.;Boakes;J. Antibiot.,2010

4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.;Bradford;Anal. Biochem.,1976

5. Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli.;Caetano;Chem. Biol.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of antimicrobial peptides clostrisin and cellulosin from Clostridium: insights into their structures, co-localized biosynthetic gene clusters, and antibiotic activity;Beilstein Journal of Organic Chemistry;2024-07-30

2. Use of the mCherry fluorescent protein to optimize the expression of class I lanthipeptides in Escherichia coli;Microbial Cell Factories;2023-08-09

3. Ruminococcus gnavus: friend or foe for human health;FEMS Microbiology Reviews;2023-03

4. Molecular Approach and Genomic Tools;Bacteriocins;2023

5. Development of recombinant lantibiotics and their potent uses;Lantibiotics as Alternative Therapeutics;2023